The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Open accessAbstract
Alexander Tsai and co-authors discuss the role of stigma in responses to the US opioid crisis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stigma: Notes on the Management of Spoiled Identity
(1969) · Postgraduate Medical Journal · doi:10.1136/pgmj.45.527.642 · Cited by 14,231
Stigma: Notes on the Management of Spoiled Identity.
Seeman, M., & Goffman, E. (1964) · American Sociological Review · doi:10.2307/2091442 · Cited by 10,716
Link, B. G., & Phelan, J. C. (2001) · Annual Review of Sociology · doi:10.1146/annurev.soc.27.1.363 · Cited by 8,848
Lippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Social conditions as fundamental causes of disease.
Link, B. G., & Phelan, J. (1995) · Journal of Health and Social Behavior · doi:10.2307/2626958 · Cited by 5,722
Clement, S., Schauman, O., Graham, T., Maggioni, F., Evans-Lacko, S., Bezborodovs, N., Morgan, C., Rüsch, N., Brown, J. S. L., & Thornicroft, G. (2015) · Psychological Medicine · doi:10.1017/s0033291714000129 · Cited by 3,152
Social Conditions as Fundamental Causes of Disease
Link, B. G., & Phelan, J. (1995) · Digital Repository at the University of Maryland · doi:10.13016/rpln-eiwa · Cited by 2,679
Stigma as a fundamental cause of population health inequalities
Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301069 · Cited by 2,674 · cited 1×
“Its persistence and its persistent effects on health are consistent with its conceptualization as a “fundamental cause” of population health inequities across multiple social and physical health outcomes [22,23].”
BackgroundLevels of racism: a theoretic framework and a gardener's tale
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.8.1212 · Cited by 2,626
Women as Policy Makers: Evidence from a Randomized Policy Experiment in India
Chattopadhyay, R., & Duflo, E. (2004) · Econometrica · doi:10.1111/j.1468-0262.2004.00539.x · Cited by 2,284
A Modified Labeling Theory Approach to Mental Disorders: An Empirical Assessment
Link, B. G., Cullen, F. T., Struening, E., Shrout, P. E., & Dohrenwend, B. P. (1989) · American Sociological Review · doi:10.2307/2095613 · Cited by 1,935 · cited 1×
“• Internalized stigma results when people with a stigmatized identity come to accept their devalued status as valid, thereby adopting for themselves the prevailing negative attitudes embedded in public stigma [29,30].”
BackgroundThe paradox of self-stigma and mental illness.
Corrigan, P. W., & Watson, A. C. (2002) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.9.1.35 · Cited by 1,872
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816 · cited 1×
“This underuse represents a missed public health opportunity, given the well-established effectiveness of opioid agonist treatment in reducing mortality [55,57].”
Backgroundvan Boekel, L. C., Brouwers, E. P. M., van Weeghel, J., & Garretsen, H. F. L. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.018 · Cited by 1,810
Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,731
Release from prison–a high risk of death for former inmates
Binswanger, I. A., Stern, M. F., Deyo, R. A., Heagerty, P. J., Cheadle, A., Elmore, J. G., & Koepsell, T. D. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa064115 · Cited by 1,684
Link, B. G. (1987) · American Sociological Review · doi:10.2307/2095395 · Cited by 1,587
Stigmatisation of people with mental illnesses
Crisp, A. H., Gelder, M. G., Rix, S., Meltzer, H. I., & Rowlands, O. J. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.1.4 · Cited by 1,457 · cited 1×
“• Public stigma [24] is driven by stereotypes about people with OUDs [18], such as their perceived dangerousness [25,26] or perceived moral failings [27], which translate into negative attitudes.”
BackgroundEvidence for effective interventions to reduce mental-health-related stigma and discrimination
Thornicroft, G., Mehta, N., Clement, S., Evans-Lacko, S., Doherty, M., Rose, D., Koschorke, M., Shidhaye, R., O'Reilly, C., & Henderson, C. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00298-6 · Cited by 1,338
Drug Overdose Deaths in the United States, 1999–2020
Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M. (2021) · doi:10.15620/cdc:112340 · Cited by 1,283
The Social Rejection of Former Mental Patients: Understanding Why Labels Matter
Link, B. G., Cullen, F. T., Frank, J., & Wozniak, J. F. (1987) · American Journal of Sociology · doi:10.1086/228672 · Cited by 1,265
Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121743 · Cited by 1,262
The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,168
Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesis
Katz, I. T., Ryu, A. E., Onuegbu, A. G., Psaros, C., Weiser, S. D., Bangsberg, D. R., & Tsai, A. C. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.3.18640 · Cited by 1,126
Self-citationVital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076 · cited 2×
“Yet only a minority of people with OUDs receive treatment of any kind, even after nonfatal overdose [55,56].”
BackgroundWalley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013) · BMJ · doi:10.1136/bmj.f174 · Cited by 999
Opioid crisis: no easy fix to its social and economic determinants
Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304187 · Cited by 923
Self-citationThe contact hypothesis re-evaluated
PALUCK, E. L., GREEN, S. A., & GREEN, D. P. (2019) · Behavioural Public Policy · doi:10.1017/bpp.2018.25 · Cited by 856
Stigma, discrimination and the health of illicit drug users
Ahern, J., Stuber, J., & Galea, S. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.10.014 · Cited by 802
Durably reducing transphobia: A field experiment on door-to-door canvassing
Broockman, D., & Kalla, J. (2016) · Science · doi:10.1126/science.aad9713 · Cited by 798
Being epileptic: coming to terms with stigma
Scambler, G., & Hopkins, A. (1986) · Sociology of Health & Illness · doi:10.1111/1467-9566.ep11346455 · Cited by 778
Structural Levels of Mental Illness Stigma and Discrimination
Corrigan, P. W., Markowitz, F. E., & Watson, A. C. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007096 · Cited by 756
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
Meta‐analysis of drug‐related deaths soon after release from prison
Merrall, E. L. C., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J., Hutchinson, S. J., & Bird, S. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02990.x · Cited by 674
Ethnicity and analgesic practice
Todd, K. H., Deaton, C., D’Adamo, A. P., & Goe, L. (2000) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(00)70099-0 · Cited by 641
Binswanger, I. A., Blatchford, P. J., Mueller, S. R., & Stern, M. F. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-9-201311050-00005 · Cited by 599
Brat, G. A., Agniel, D., Beam, A., Yorkgitis, B., Bicket, M., Homer, M., Fox, K. P., Knecht, D. B., McMahill-Walraven, C. N., Palmer, N., et al. (2018) · BMJ · doi:10.1136/bmj.j5790 · Cited by 591
Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use
Barnett, M. L., Olenski, A. R., & Jena, A. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmsa1610524 · Cited by 567
Self-citationThe Race Discrimination System
Reskin, B. (2012) · Annual Review of Sociology · doi:10.1146/annurev-soc-071811-145508 · Cited by 558
Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014) · Psychiatric Services · doi:10.1176/appi.ps.201400140 · Cited by 545
Self-citationMedia madness: public images of mental illness
(1996) · Choice Reviews Online · doi:10.5860/choice.33-5754 · Cited by 541
Strategies used by people who inject drugs to avoid stigma in healthcare settings
Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., Mimiaga, M. J., Saitz, R., & Bazzi, A. R. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.037 · Cited by 524
Pescosolido, B. A., Martin, J. K., Lang, A., & Olafsdottir, S. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.03.018 · Cited by 522
Marshall, B. D., Milloy, M.-J., Wood, E., Montaner, J. S., & Kerr, T. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62353-7 · Cited by 479
Kelly, J. F., & Westerhoff, C. M. (2010) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.10.010 · Cited by 471
Stigma at every turn: Health services experiences among people who inject drugs
Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.004 · Cited by 469
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Lagisetty, P. A., Ross, R., Bohnert, A., Clay, M., & Maust, D. T. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.0876 · Cited by 464
Evans-Lacko, S., Brohan, E., Mojtabai, R., & Thornicroft, G. (2012) · Psychological Medicine · doi:10.1017/s0033291711002558 · Cited by 427
Stigma and Treatment for Alcohol Disorders in the United States
Keyes, K. M., Hatzenbuehler, M. L., McLaughlin, K. A., Link, B., Olfson, M., Grant, B. F., & Hasin, D. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq304 · Cited by 425
Self-citationBohnert, A. S. B., Guy, G. P., & Losby, J. L. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1243 · Cited by 409
No Shortcuts to Safer Opioid Prescribing
Dowell, D., Haegerich, T., & Chou, R. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1904190 · Cited by 408
Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N. O., & Baldwin, G. T. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6751521e1 · Cited by 403
Kariisa, M., Scholl, L., Wilson, N., Seth, P., & Hoots, B. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6817a3 · Cited by 400
Netherland, J., & Hansen, H. B. (2016) · Culture, Medicine, and Psychiatry · doi:10.1007/s11013-016-9496-5 · Cited by 387
Trends in Mortality for Medicare Beneficiaries Treated in the Emergency Department From 2009 to 2016
Burke, L. G., Epstein, S. K., Burke, R. C., Orav, E. J., & Jha, A. K. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.4866 · Cited by 382
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
Oviedo-Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D., Anis, A., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 375
Female Socialization: How Daughters Affect Their Legislator Fathers' Voting on Women's Issues
Washington, E. L. (2008) · American Economic Review · doi:10.1257/aer.98.1.311 · Cited by 368
Twin epidemics: The surging rise of methamphetamine use in chronic opioid users
Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.029 · Cited by 355
Luoma, J. B., Kohlenberg, B. S., Hayes, S. C., & Fletcher, L. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0026070 · Cited by 336
Dugosh, K., Abraham, A., Seymour, B., McLoyd, K., Chalk, M., & Festinger, D. (2016) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000193 · Cited by 333
Theories on drug abuse. Selected contemporary perspectives.
Lettieri, D. J., Sayers, M., & Pearson, H. W. (1980) · PubMed · Cited by 333
Green, T. C., Clarke, J., Brinkley-Rubinstein, L., Marshall, B. D. L., Alexander-Scott, N., Boss, R., & Rich, J. D. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4614 · Cited by 320
White opioids: Pharmaceutical race and the war on drugs that wasn’t
Netherland, J., & Hansen, H. (2017) · BioSocieties · doi:10.1057/biosoc.2015.46 · Cited by 314
Radcliffe, P., & Stevens, A. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.06.004 · Cited by 312
King, N. B., Fraser, V., Boikos, C., Richardson, R., & Harper, S. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.301966 · Cited by 310
Gilmore, N., & Somerville, M. A. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90365-4 · Cited by 309
Barriers to treatment: Why alcohol and drug abusers delay or never seek treatment
Cunningham, J. A., Sobell, L. C., Sobell, M. B., Agrawal, S., & Toneatto, T. (1993) · Addictive Behaviors · doi:10.1016/0306-4603(93)90036-9 · Cited by 307
Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600056 · Cited by 307
Self-citationWinkelman, T. N. A., Chang, V. W., & Binswanger, I. A. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0558 · Cited by 301
Why aren't physicians prescribing more buprenorphine?
Huhn, A. S., & Dunn, K. E. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.04.005 · Cited by 291
Intensity of Chronic Pain — The Wrong Metric?
Ballantyne, J. C., & Sullivan, M. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1507136 · Cited by 284
Gladden, R. M., O’Donnell, J., Mattson, C. L., & Seth, P. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6834a2 · Cited by 284
The association between perceived stigma and substance use disorder treatment outcomes: a review
Crapanzano, K., Hammarlund, R., Ahmad, B., Hunsinger, N., & Kullar, R. (2018) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s183252 · Cited by 278
History of The Joint Commission’s Pain Standards: Lessons for Today’s Prescription Opioid Epidemic
Baker, D. W. (2017) · JAMA · doi:10.1001/jama.2017.0935 · Cited by 276
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7621 · Cited by 274
Self-citationEarnshaw, V., Smith, L., & Copenhaver, M. (2013) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-012-9402-5 · Cited by 272
Self-citationCo-occurring epidemics, syndemics, and population health
Tsai, A. C., Mendenhall, E., Trostle, J. A., & Kawachi, I. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30403-8 · Cited by 268 · cited 1×
“Concomitant with the rapid expansion in the magnitude of the opioid overdose crisis is an expansion in its scope, with increasingly syndemic [6] involvement of cocaine and psychostimulants [7–10].”
BackgroundSelf-citationNunn, A., Zaller, N., Dickman, S., Trimbur, C., Nijhawan, A., & Rich, J. D. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.06.015 · Cited by 264
McGinty, E. E., Goldman, H. H., Pescosolido, B., & Barry, C. L. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.12.010 · Cited by 254
Self-citationRisk Reduction for the Acquired Immunodeficiency Syndrome Among Intravenous Drug Users
JARLAIS, D. C. D., FRIEDMAN, S. R., & HOPKINS, W. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-5-755 · Cited by 252
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
Haffajee, R. L., Bohnert, A. S. B., & Lagisetty, P. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.12.022 · Cited by 252
Abouk, R., Pacula, R. L., & Powell, D. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0272 · Cited by 242
Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic
Pitt, A. L., Humphreys, K., & Brandeau, M. L. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304590 · Cited by 234
The Public Health Impact of Needle Exchange Programs in the United States and Abroad
Lane, S. D. (1993) · Cited by 233
Hansen, H. B., Siegel, C. E., Case, B. G., Bertollo, D. N., DiRocco, D., & Galanter, M. (2013) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-013-9341-3 · Cited by 225
Long-term retention in Office Based Opioid Treatment with buprenorphine
Weinstein, Z. M., Kim, H. W., Cheng, D. M., Quinn, E., Hui, D., Labelle, C. T., Drainoni, M.-L., Bachman, S. S., & Samet, J. H. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.12.010 · Cited by 225
Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., Flynn, P. M., Welsh, W. N., Stein, L. A. R., Sacks, S., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2011.611460 · Cited by 223
Degenhardt, L., Larney, S., Kimber, J., Gisev, N., Farrell, M., Dobbins, T., Weatherburn, D. J., Gibson, A., Mattick, R., Butler, T., et al. (2014) · Addiction · doi:10.1111/add.12536 · Cited by 223
Broyles, L. M., Binswanger, I. A., Jenkins, J. A., Finnell, D. S., Faseru, B., Cavaiola, A., Pugatch, M., & Gordon, A. J. (2014) · Substance Abuse · doi:10.1080/08897077.2014.930372 · Cited by 220
Schnittker, J. (2008) · Social Science & Medicine · doi:10.1016/j.socscimed.2008.07.007 · Cited by 219
Schroeder, A. R., Dehghan, M., Newman, T. B., Bentley, J. P., & Park, K. T. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5419 · Cited by 216
Kroenke, K., Alford, D. P., Argoff, C., Canlas, B., Covington, E., Frank, J. W., Haake, K. J., Hanling, S., Hooten, W. M., Kertesz, S. G., et al. (2019) · Pain Medicine · doi:10.1093/pm/pny307 · Cited by 214
Is the Prescription Opioid Epidemic a White Problem?
Hansen, H., & Netherland, J. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303483 · Cited by 207
Trends in Black and White Opioid Mortality in the United States, 1979–2015
Alexander, M. J., Kiang, M. V., & Barbieri, M. (2018) · Epidemiology · doi:10.1097/ede.0000000000000858 · Cited by 205
Self-citationEarnshaw, V. A., Smith, L. R., Cunningham, C. O., & Copenhaver, M. M. (2015) · Journal of Health Psychology · doi:10.1177/1359105313507964 · Cited by 203
Self-citationMethadone as Social Control: Institutionalized Stigma and the Prospect of Recovery
Harris, J., & McElrath, K. (2012) · Qualitative Health Research · doi:10.1177/1049732311432718 · Cited by 201
Drivers of the fatal drug epidemic
Ruhm, C. J. (2019) · Journal of Health Economics · doi:10.1016/j.jhealeco.2019.01.001 · Cited by 197
Marsden, J., Stillwell, G., Jones, H., Cooper, A., Eastwood, B., Farrell, M., Lowden, T., Maddalena, N., Metcalfe, C., Shaw, J., et al. (2017) · Addiction · doi:10.1111/add.13779 · Cited by 187
Opioid medication discontinuation and risk of adverse opioid-related health care events
Mark, T. L., & Parish, W. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.05.001 · Cited by 180
McGinty, E. E., Pescosolido, B. A., Kennedy‐Hendricks, A., & Barry, C. L. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201700076 · Cited by 179
Self-citationGordon, M. S., Kinlock, T. W., Schwartz, R. P., & O’Grady, K. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.002238.x · Cited by 176
Primary Care and the Opioid-Overdose Crisis — Buprenorphine Myths and Realities
Wakeman, S. E., & Barnett, M. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1802741 · Cited by 175
Self-citationFung, K. M. T., Tsang, H. W. H., & Cheung, W. M. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.02.013 · Cited by 173
Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis
Yarborough, B. J. H., Stumbo, S. P., McCarty, D. W., Mertens, J. R., Weisner, C. M., & Green, C. A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.031 · Cited by 170
Venkataramani, A. S., Bair, E. F., O’Brien, R. L., & Tsai, A. C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5686 · Cited by 168
Self-citationIntervention stigma: How medication-assisted treatment marginalizes patients and providers
Madden, E. F. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.05.027 · Cited by 167
Legal changes to increase access to naloxone for opioid overdose reversal in the United States
Davis, C. S., & Carr, D. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.013 · Cited by 166
Brener, L., von Hippel, W., von Hippel, C., Resnick, I., & Treloar, C. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00173.x · Cited by 166
Koester, S., Mueller, S. R., Raville, L., Langegger, S., & Binswanger, I. A. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.008 · Cited by 165
Enemies of the People: The Moral Dimension to Public Health
Morone, J. A. (1997) · Journal of Health Politics, Policy and Law · doi:10.1215/03616878-22-4-993 · Cited by 163
Meinhofer, A., & Witman, A. E. (2018) · Journal of Health Economics · doi:10.1016/j.jhealeco.2018.06.004 · Cited by 163
Initial Opioid Prescriptions among U.S. Commercially Insured Patients, 2012–2017
Zhu, W., Chernew, M. E., Sherry, T. B., & Maestas, N. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1807069 · Cited by 162
Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver
Fiscella, K., Wakeman, S. E., & Beletsky, L. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3685 · Cited by 158
Self-citationAddressing the Opioid Epidemic
Nelson, L. S., Juurlink, D. N., & Perrone, J. (2015) · JAMA · doi:10.1001/jama.2015.12397 · Cited by 154
Green, T. C., Case, P., Fiske, H., Baird, J. B., Cabral, S., Burstein, D., Schwartz, V., Potter, N., Walley, A. Y., & Bratberg, J. P. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.01.013 · Cited by 152
State legal innovations to encourage naloxone dispensing
Davis, C. S., & Carr, D. H. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2016.11.007 · Cited by 140
McGinty, E. E., Barry, C. L., Stone, E. M., Niederdeppe, J., Kennedy‐Hendricks, A., Linden, S., & Sherman, S. G. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.02.026 · Cited by 139
Self-citationSuzuki, J., Johnson, J., Montgomery, M. W., Hayden, M. C., & Price, C. N. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy194 · Cited by 138
Drug Overdose Deaths Involving Fentanyl, 2011-2016.
Spencer, M. R. T., Warner, M., Bastian, B. A., Trinidad, J. P., & Hedegaard, H. B. (2019) · PubMed · Cited by 136
Babu, K. M., Brent, J. A., & Juurlink, D. N. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807054 · Cited by 133
Stigmatizing language in news media coverage of the opioid epidemic: Implications for public health
McGinty, E. E., Stone, E. M., Kennedy‐Hendricks, A., & Barry, C. L. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.03.018 · Cited by 131
Self-citationJones, C. M., Lurie, P. G., & Throckmorton, D. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7799 · Cited by 130
Binswanger, I. A., Koester, S. K., Mueller, S. R., Gardner, E. M., Goddard, K., & Glanz, J. M. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3394-3 · Cited by 129
Primary care physicians’ perspectives on the prescription opioid epidemic
Kennedy-Hendricks, A., Busch, S. H., McGinty, E., Bachhuber, M., Niederdeppe, J., Gollust, S. E., Webster, D. W., Fiellin, D., & Barry, C. L. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.05.010 · Cited by 127
Self-citationDrive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States
Joudrey, P. J., Edelman, E. J., & Wang, E. A. (2019) · JAMA · doi:10.1001/jama.2019.12562 · Cited by 121
Darnall, B. D., Juurlink, D. N., Kerns, R. D., Mackey, S., Dorsten, B. V., Humphreys, K. N., Gonzalez-Sotomayor, J. A., Furlan, A. D., Gordon, A. J., Gordon, D. B., et al. (2018) · Pain Medicine · doi:10.1093/pm/pny228 · Cited by 119
McGinty, E. E., Kennedy‐Hendricks, A., Baller, J. B., Niederdeppe, J., Gollust, S. E., & Barry, C. L. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201500065 · Cited by 113
Self-citationPhysician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment
Stein, B. D., Sorbero, M., Dick, A. W., Pacula, R. L., Burns, R. M., & Gordon, A. J. (2016) · JAMA · doi:10.1001/jama.2016.10542 · Cited by 113
Beetham, T., Saloner, B. K., Wakeman, S. E., Gaye, M., & Barnett, M. L. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3457 · Cited by 111
Self-citationIrvine, M. A., Buxton, J. A., Otterstatter, M. C., Balshaw, R. F., Gustafson, R., TYNDALL, M. W., Kendall, P., Kerr, T. H., Gilbert, M., & Coombs, D. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30044-6 · Cited by 108
Kiang, M. V., Basu, S., Chen, J. T., & Alexander, M. J. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.0040 · Cited by 107
Self-citationPrevention of Fatal Opioid Overdose
Beletsky, L. A., Rich, J. D., & Walley, A. Y. (2012) · JAMA · doi:10.1001/jama.2012.14205 · Cited by 103
Self-citationArticle Commentary: Turning the Tide or Riptide? The Changing Opioid Epidemic
Kertesz, S. (2017) · Substance Abuse · doi:10.1080/08897077.2016.1261070 · Cited by 101
Bachhuber, M. A., McGinty, E. E., Kennedy‐Hendricks, A., Niederdeppe, J., & Barry, C. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130050 · Cited by 100
Self-citationAccess to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids
Lagisetty, P., Healy, N. A., Garpestad, C., Jannausch, M. L., Tipirneni, R., & Bohnert, A. S. B. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.6928 · Cited by 100
The Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
Manhapra, A., Arias, A. J., & Ballantyne, J. C. (2018) · Substance Abuse · doi:10.1080/08897077.2017.1381663 · Cited by 98
Latkin, C. A., Davey-Rothwell, M. A., Yang, J.-Y., & Crawford, N. D. (2012) · Journal of Urban Health · doi:10.1007/s11524-012-9753-z · Cited by 98
Amiri, S., Lutz, R. B., Socias, M. E., McDonell, M. G., Roll, J. M., & Amram, O. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.07.006 · Cited by 98
Gaither, J. R., Gordon, K. S., Crystal, S., Edelman, E. J., Kerns, R. D., Justice, A. C., Fiellin, D. A., & Becker, W. C. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.05.033 · Cited by 98
A crisis of opioids and the limits of prescription control: United States
Kertesz, S. G., & Gordon, A. J. (2018) · Addiction · doi:10.1111/add.14394 · Cited by 96
Manhapra, A., Agbese, E., LESLIE, D. L., & Rosenheck, R. A. (2018) · Psychiatric Services · doi:10.1176/appi.ps.201700363 · Cited by 93
Latkin, C. A., Gicquelais, R. E., Clyde, C., Dayton, L., Davey-Rothwell, M. A., German, D., Falade-Nwulia, S., Saleem, H. T., Fingerhood, M., & Tobin, K. E. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.03.012 · Cited by 93
Vlahov, D., Jarlais, D. C. D., Goosby, E., et al. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.12.s70 · Cited by 91
Patient Perspectives on Choosing Buprenorphine Over Methadone in an Urban, Equal‐Access System
Gryczynski, J., Jaffe, J. H., Schwartz, R. P., Dušek, K., Gugsa, N., Monroe, C. L., O’Grady, K. E., Olsen, Y. K., & Mitchell, S. G. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2012.12004.x · Cited by 90
Cocaine, Race, and Equal Protection
Sklansky, D. A. (1995) · Stanford Law Review · doi:10.2307/1229193 · Cited by 89
Understanding public stigma toward substance dependence
Janulis, P. F., Ferrari, J. R., & Fowler, P. J. (2013) · Journal of Applied Social Psychology · doi:10.1111/jasp.12070 · Cited by 89
Davis, C. S., & Carr, D. H. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.04.002 · Cited by 89
Associated Press stylebook and briefing on media law
Christian, D., Jacobsen, S., Minthorn, D., Froke, P., & Kent, T. (2009) · CERN Document Server (European Organization for Nuclear Research) · Cited by 87
Prescribing patterns of buprenorphine waivered physicians
Parks, C. L., Doyle, E., Kreiner, P. W., Jones, C. M., Dubenitz, J., Horan, A., & Stein, B. D. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.002 · Cited by 83
Preventing Opiate Overdose Deaths: Examining Objections to Take-Home Naloxone
Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2010.0935 · Cited by 82
Wakeman, S. E., & Rich, J. D. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3799-7 · Cited by 81
Self-citationThe affordable care act transformation of substance use disorder treatment
Abraham, A. J., Andrews, C. M., Grogan, C. M., D’Aunno, T., Humphreys, K. N., Pollack, H. A., & Friedmann, P. D. (2017) · American Journal of Public Health · doi:10.2105/ajph.2016.303558 · Cited by 79
Rapoport, A. B., Fischer, L. S., Santibanez, S. S., Beekmann, S. E., Polgreen, P. M., & Rowley, C. F. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy132 · Cited by 78
The Untapped Potential of Office-Based Buprenorphine Treatment
Sigmon, S. C. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2421 · Cited by 74
Kulesza, M., Watkins, K. E., Ober, A. J., Osilla, K. C., & Ewing, B. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.08.002 · Cited by 73
Burns, R. M., Pacula, R. L., Bauhoff, S., Gordon, A. J., Hendrikson, H., LESLIE, D. L., & Stein, B. D. (2015) · Substance Abuse · doi:10.1080/08897077.2015.1080208 · Cited by 72
Dineen, K. K., & DuBois, J. M. (2016) · American Journal of Law & Medicine · doi:10.1177/0098858816644712 · Cited by 72
Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid
Frazier, W. T., Cochran, G., Lo‐Ciganic, W., Gellad, W. F., Gordon, A. J., Chang, C. H., & Donohue, J. M. (2017) · JAMA · doi:10.1001/jama.2017.7818 · Cited by 72
Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary
McElrath, K. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1342662 · Cited by 70
Green, T. C., Bowman, S. E., Zaller, N. D., Ray, M., Case, P., & Heimer, R. (2013) · Substance Use & Misuse · doi:10.3109/10826084.2013.787099 · Cited by 69
Liver Transplantation and Opioid Dependence
Koch, M. (2001) · JAMA · doi:10.1001/jama.285.8.1056 · Cited by 68
Buprenorphine prescribing practice trends and attitudes among New York providers
Kermack, A. S., Flannery, M., Tofighi, B., McNeely, J., & Lee, J. D. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.10.005 · Cited by 66
Epidemiology of Failed Tobacco Control Legislation
Moore, S., Wolfe, S. M., Lindes, D., & Douglas, C. E. (1994) · JAMA · doi:10.1001/jama.1994.03520150039034 · Cited by 64
Patterns of Potential Opioid Misuse and Subsequent Adverse Outcomes in Medicare, 2008 to 2012
Carey, C. M., Jena, A. B., & Barnett, M. L. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3065 · Cited by 60
Self-citationBarry, C. L., Sherman, S. G., & McGinty, E. E. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304588 · Cited by 59
Self-citationSkehan, J., Greenhalgh, S., Hazell, T., & Pirkis, J. (2006) · International Journal of Mental Health Promotion · doi:10.1080/14623730.2006.9721749 · Cited by 58
Race and Gender Are Associated with Opioid Dose Reduction Among Patients on Chronic Opioid Therapy
Buonora, M. J., Perez, H. R., Heo, M., Cunningham, C. O., & Starrels, J. L. (2018) · Pain Medicine · doi:10.1093/pm/pny137 · Cited by 57
Friedmann, P. D., & Schwartz, R. P. (2012) · Addiction Science & Clinical Practice · doi:10.1186/1940-0640-7-10 · Cited by 52
News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic
Kennedy‐Hendricks, A., Levin, J., Stone, E. M., McGinty, E. E., Gollust, S. E., & Barry, C. L. (2019) · Health Affairs · doi:10.1377/hlthaff.2018.05075 · Cited by 51
Self-citationDavis, C. S., & Carr, D. H. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.07.006 · Cited by 46
America's Favorite Antidote: Drug-Induced Homicide in the Age of the Overdose Crisis
Beletsky, L. A. (2018) · Utah law review · doi:10.63140/igcy_z3qq4 · Cited by 44
Self-citationAccess to and Payment for Office-Based Buprenorphine Treatment in Ohio
Parran, T. V., Muller, J. Z., Chernyak, E., Adelman, C., Reyes, C. M. D., Rowland, D. Y., & Kolganov, M. (2017) · Substance Abuse Research and Treatment · doi:10.1177/1178221817699247 · Cited by 43
Impact of Medicaid restrictions on availability of buprenorphine in addiction treatment programs
Andrews, C. M., Abraham, A. J., Grogan, C. M., Westlake, M. A., Pollack, H. A., & Friedmann, P. D. (2019) · American Journal of Public Health · doi:10.2105/ajph.2018.304856 · Cited by 43
Medicaid Coverage of Medications to Treat Alcohol and Opioid Dependence
Mark, T. L., Lubran, R., McCance‐Katz, E. F., Chalk, M., & Richardson, J. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.04.009 · Cited by 42
Nunn, A. S., Zaller, N. D., Dickman, S., Trimbur, M. C., Nijhawan, A., & Rich, J. D. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.002 · Cited by 42
Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program
Allen, B., Harocopos, A., & Chernick, R. (2019) · Behavioral Medicine · doi:10.1080/08964289.2018.1555129 · Cited by 42
Fleming, J. N., Lai, J. C., Te, H. S., Said, A., Spengler, E. K., & Rogal, S. S. (2017) · Clinical Transplantation · doi:10.1111/ctr.13119 · Cited by 36
Managing multiple relationships in rural communities: Neutrality and boundary violations.
Faulkner, K. K., & Faulkner, T. A. (1997) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.1997.tb00111.x · Cited by 35
Aronowitz, S. V., & Laurent, J. S. (2016) · Journal of Correctional Health Care · doi:10.1177/1078345816634079 · Cited by 35
Staff perspectives on methadone maintenance therapy (MMT) in a large southwestern jail
McMillan, G. P., & Lapham, S. C. (2005) · Addiction Research & Theory · doi:10.1080/16066350512331328159 · Cited by 28
Long‐Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine
Montalvo, C., Stankiewicz, B., Brochier, A., Henderson, D. C., & Borba, C. P. C. (2019) · American Journal on Addictions · doi:10.1111/ajad.12896 · Cited by 26
Arredondo, J., Beletsky, L. A., Baker, P. A., et al. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305030 · Cited by 22
Self-citationTreatment as long-term prevention
Siedner, M. J., Musinguzi, N., Tsai, A. C., Muzoora, C. K., Kembabazi, A., Weiser, S. D., Bennett, J., Hunt, P. W., Martin, J. N., Haberer, J. E., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000136 · Cited by 17
Self-citationAccess to Treatment for Alcohol Use Disorder at US Health Centers: a National Study
Bearnot, B. I., Rigotti, N. A., & Baggett, T. P. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4631-3 · Cited by 17
Opioid Use Disorder, Stigma, and Transplantation: A Call to Action
Wakeman, S. E., Ladin, K., Brennan, T. K., & Chung, R. T. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1099 · Cited by 13
Self-citationEvaluating the impact of Affordable Care Act repeal on America's opioid epidemic
Wen, L. S., Behrle, E., & Tsai, A. C. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002380 · Cited by 10
Self-citationNo One Should Have to Prove Their Worth to Get Medical Care, Regardless of Addiction or Pain
Szalavitz, M. (2018) · Narrative Inquiry in Bioethics · doi:10.1353/nib.2018.0072 · Cited by 5
How Should the United States Respond to the Opioid Addiction and Overdose Epidemic?
Humphreys, K. N., & Pollack, H. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-11908-9_10 · Cited by 4
Cited by
The stigma system: How sociopolitical domination, scapegoating, and stigma shape public health
Friedman, S. R., Williams, L. D., Guarino, H., Mateu‐Gelabert, P., Krawczyk, N., Hamilton, L., Walters, S. M., Ezell, J. M., Khan, M., Di Iorio, J., et al. (2022) · Journal of Community Psychology · doi:10.1002/jcop.22581 · Cited by 98
The Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
Manhapra, A., Arias, A. J., & Ballantyne, J. C. (2018) · Substance Abuse · doi:10.1080/08897077.2017.1381663 · Cited by 98
McNeil, R., Fleming, T., Collins, A. B., Czechaczek, S., Mayer, S., & Boyd, J. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108666 · Cited by 30
Guerin, A., & Kim, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212259 · Cited by 22
“, being perceived as dangerous, immoral, and having a lower socioeconomic status), discrimination and eliciting negative emotional reactions [35], which may hinder access to treatment and care [36,37].”
Research, A. I. F., Latimore, A., Salisbury- Afshar, E., University of Wisconsin–Madison, Duff, N., National Academy of Medicine, Freiling, E., National Academy of Medicine, Kellett, B., Research, A. I. F., et al. (2023) · NAM Perspectives · doi:10.31478/202309b · Cited by 22
Metadata
- Authors
- Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-11-26
- Volume
- 16
- Issue
- 11
- Pages
- e1002969
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2990376616
- Cited by
- 437
- References
- 190
- FWCI
- 40.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.